Malaria Diagnostics Market Size, Share & Trends Report

Malaria Diagnostics Market Size, Share & Trends Analysis Report By Technology (Rapid Diagnostic Tests, Microscopy, Molecular Diagnostic Tests), By Region, Competitive Landscape, And Segment Forecasts, 2018 - 2025

  • Published Date: Aug, 2018
  • Base Year for Estimate: 2017
  • Report ID: 978-1-68038-711-7
  • Format: Electronic (PDF)
  • Historical Data: 2014 - 2016
  • Number of Pages: 83

Industry Insights

The global malaria diagnostics market size was valued at USD 628.5 million in 2017 and is anticipated to witness a CAGR of 4.5% during the forecast period. Rising demand for diagnostics in malaria endemic nations, introduction of novel diagnostic techniques, and rising investments by government and private companies would drive the market.

The tropical disease caused by female Anopheles mosquito, infected by the Plasmodium species caused over 4, 45,000 deaths globally in the year 2016, as stated by the World Health Organization. Statistics from the same source indicate that over 216 million cases of the disease were recorded globally, with over 90% cases being reported from Africa, 7% from South East Asia, and 2% from the Eastern Mediterranean region. Rising disease incidences are further anticipated to drive the market.

India malaria diagnostics market

Thus, increasing demand for diagnostics methods is one of the key factors augmenting the market growth. Malaria is one of the most widespread life-threatening diseases, commonly occurring in the tropical and subtropical regions as a result of changing climate, low economic growth, underdeveloped healthcare infrastructure, and low access to advanced treatment.

Malaria is still one of the leading causes of death in many African, Asian, and Latin American countries such as Uganda, Democratic Republic of Congo, Columbia, Peru, and India. Malaria during pregnancy can affect in more than one way causing low birth weights, stillbirths, and congenital infection. According to Centers for Disease Prevention, pregnant women are three times more susceptible to malaria infections. Rapid diagnosis and subsequent treatment plans are thus vital in management of the disease. Rising number of such infections are thereby generating a demand for easy and rapid diagnostic techniques.

Technological advancements are expected to be one of the key drivers of the market. Advancements are likely to improve access to diagnostics tests, especially in remote areas, wherein there is lack of skilled professionals for testing.

Increasing investments by government and private investors in order to curb prevalence of the disease is also one of the major factors driving market expansion. According to data from WHO, in 2016, approximately USD 2.7 billion were invested in disease elimination and control by private international investors and government authorities of malaria endemic nations. Over 312 million rapid diagnostic tests were delivered globally, mostly in the WHO African region, which is the worst affected region. Thus, this factor is anticipated to drive the market further.

Technology Insights

Based on technology, the market is segmented into microscopy, rapid diagnostic tests, and molecular diagnostic tests including conventional Polymerase Chain Reaction (PCR) and Real Time-Polymerase Chain Reaction (RT-PCR). Microscopy held the largest market share owing to its high adoption and factors such as accurate diagnosis and cost effectiveness.

Microscopy is one of the traditional and most reliable diagnostic methods. According to estimates from WHO, over 204 million microscopic malaria tests were conducted globally. The largest number of these tests were performed in India with the highest burden of the disease in Southeast Asia. Malaria parasites including P. falciparum, P. malariae, P. ovale, and P. vivax, at different stages of life can be identified through this method. Additionally, the parasite density can also be quantified to accordingly design treatment plans. Accurate diagnosis offered by molecular tests is contributing to its increasing adoption.

Europe malaria diagnostics market

Rapid diagnostic tests (RDT) is another method of choice used for detecting specific malaria antigens in the blood sample. As of 2017, the market is estimated to be led by Africa owing to the highest disease burden, as well as limited access of microscopy services in the underprivileged parts of the region. Estimates from WHO indicate that over 312 million RDTs were delivered globally in the year 2016. According to National malaria control program reports and sales data from manufacturers, 225 million P. falciparum tests were delivered in Africa, while the remaining were combination tests for P. falciparum, P. malariae, P. ovale, and P. vivax.

Molecular diagnostic tests include Polymerase Chain Reaction (PCR) and Real-Time-Polymerase Chain Reaction (RT-PCR). The usage of quantitative PCR or qPCR using DNA extracted from blood samples have been used to detect low parasite counts or mixed infections. These tests are accurate, highly sensitive, and capable of detecting low parasite count. However, the market share of these tests is less significant owing to high cost associated with them along with requirements of specialized laboratories and skilled workforce.

Regional Insights

The malaria diagnostics market is analyzed for Africa, Eastern Mediterranean, Southeast Asia, Western Pacific, Americas, and Europe. Africa is expected to be the dominant regional market owing to the highest disease burden caused due to factors such as local weather conditions, socio-economic instability, and poor healthcare system. P. falciparum is the most prevalent disease parasite in this region, accounting for an estimated 99% of all cases in Africa. According to the WHO, an estimated 90% of the global malaria cases and 91% of global malaria deaths were recorded in the African region. These facts are indicative of the rising disease prevalence in the region.

Southeast Asia is estimated to hold the second position in the market with India accounting for the largest share of the regional market. The Europe market, by value, is expected to hold the least share due to increasing number of malaria-free countries in the region. As of 2015, Southeast Asia accounted for around 10% of the global cases, whereas the mortality rate was around 7% in the same year. The diagnostic testing, by volume, in India is led by microscopy testing. With rising awareness and increasing funding from private sector, care-based surveillance systems, and national governments, the need for diagnostic testing is anticipated to increase, thereby propelling market development.

Malaria Diagnostics Market Share Insights

The global market is a blend of large, well-established public and private firms. Key companies in the market are Access Bio. Inc.; Abbott Laboratories; Premier Medical Corporation Pvt. Ltd.; Sysmex Partec GmbH; bioMérieux; Beckman Coulter Inc.; Siemens Healthineers; Leica Microsystems GmbH; Nikon Corporation; Olympus Corporation; and Bio-Rad Laboratories, Inc. Most of these companies have an extensive product portfolio, strong global presence, and distribution channels in the market.For instance, bioMérieux has a vast network of distributors in more than 150 countries through 42 subsidiaries for providing diagnostic solutions across the globe.

Report Scope



Base year for estimation


Actual estimates/Historical data

2014 - 2016

Forecast period

2018 - 2025

Market representation                         

Revenue in USD Million and CAGR from 2014 to 2025

Regional scope

Africa, East Mediterranean, America, Europe, South-East Asia, and Western Pacific

Country scope

Nigeria, Democratic Republic of the Congo, Uganda, India, Myanmar, Indonesia, Saudi Arabia, Pakistan, China, Papua New Guinea, Cambodia, Venezuela, Brazil, Colombia, Turkey, France, U.K., and Germany

Report coverage  

Revenue forecast, company share, competitive landscape, growth factors and trends

15% free customization scope (equivalent to 5 analyst working days)

If you need specific information, which is not currently within the scope of the report, we will provide it to you as a part of customization

Segments Covered in the Report

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2014 to 2025. For the purpose of this study, Grand View Research has segmented the global malaria diagnostics market report on the basis of technology and region:

  • Technology Outlook (Revenue, USD Million, 2014 - 2025)

    • Microscopy

    • Rapid Diagnostic Tests

    • Molecular Diagnostic Tests

      • Conventional PCR

      • Real-Time PCR (quantitative PCR or qPCR)

  • Regional Outlook (Revenue, USD Million, 2014 - 2025)

    • Africa

      • Nigeria

      • Democratic Republic of the Congo

      • Uganda

    • Southeast Asia

      • India

      • Myanmar

      • Indonesia

    • Eastern Mediterranean

      • Saudi Arabia

      • Pakistan

    • Western Pacific

      • China

      • Papua New Guinea

      • Cambodia

    • Americas

      • Venezuela

      • Brazil

      • Colombia

    • Europe

      • Turkey

      • France

      • U.K.

      • Germany

Key questions answered by the report
Request for Customization

Choose License Type

Single User - $4,950
Multi User (2-5) - $5,950
Enterprise Access - $7,950

Buy Chapters or Sections

Avail customized purchase options to meet your exact research needs:

  • Buy sections of this report
  • Buy country level reports
  • Request for historical data
  • Request discounts available for Start-Ups & Universities

Why Choose Us

  • Research support

    24/5 Research support

    Get your queries resolved from an industry expert.

  • Custom research service

    Custom research service

    Design an exclusive study to serve your research needs.

  • Quality assurance

    Quality assurance

    A testimonial for service in the form of BBB "A" Accreditation.

  • BBB Rating dandb
  • Information security

    Information security

    Your personal and confidential information is safe and secure.

  • grand view research PCI DSS complaint grand view research paypal verified